Neoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trial - Concepedia

Concepedia

Publication | Open Access

Neoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trial

DOI Full Paper Access

582

Citations

40

References

2021

Year

Tina Cascone, William N. William, Annikka Weissferdt, Cheuk Hong Leung, Heather Lin, Apar Pataer, Myrna C. B. Godoy, Brett W. Carter, Lorenzo Federico, Alexandre Reuben,

Nature Medicine

Neostar TrialMedicineImmune Checkpoint InhibitorCancer TreatmentPhase 2OncologyRadiation OncologyLung CancerNeoadjuvant Nivolumab

References

	Year	Citations

Page 1

Page 1